Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerry Kenna

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Toxicologic Pathology|June 8, 2012
Differential effect of troglitazone on the human bile acid transporters, MRP2 and BSEP, in the PXB hepatic chimeric mouseJohn R Foster, Matt Jacobsen, Gerry Kenna, et al.
Archives of Toxicology|May 10, 2012
Systems biology tools for toxicologySuzanne Geenen, Peter Neal Taylor, Jacky L Snoep, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 11, 2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modificationDaniel J Warner, Hongming Chen, Louis-David Cantin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 2, 2012
Characterization of THLE-cytochrome P450 (P450) cell lines: gene expression background and relationship to P450-enzyme activityYalda Soltanpour, Constanze Hilgendorf, Marie M Ahlström, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|May 2, 2013
Multiscale modelling approach combining a kinetic model of glutathione metabolism with PBPK models of paracetamol and the potential glutathione-depletion biomarkers ophthalmic acid and 5-oxoproline in humans and ratsSuzanne Geenen, James W T Yates, J Gerry Kenna, et al.
Regulatory Toxicology and Pharmacology : RTP|February 26, 2022
Use of in vitro metabolism and biokinetics assays to refine predicted in vivo and in vitro internal exposure to the cosmetic ingredient, phenoxyethanol, for use in risk assessmentNicola J Hewitt, John Troutman, Julia Przibilla, et al.
Toxicology Research|August 10, 2018
Improved hepatic physiology in hepatic cytochrome P450 reductase null (HRN™) mice dosed orally with fenclozic acidJames A Akingbasote, Alison J Foster, Huw B Jones, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 15, 2011
HPLC-MS/MS methods for the quantitative analysis of 5-oxoproline (pyroglutamate) in rat plasma and hepatic cell line culture mediumSuzanne Geenen, Cristina Guallar-Hoyas, Filippos Michopoulos, et al.
Chemical Research in Toxicology|December 14, 2012
Bioactivation of the cannabinoid receptor antagonist rimonabant to a cytotoxic iminium ion metaboliteAlison J Foster, Lucy H Prime, Frida Gustafsson, et al.
Regulatory Toxicology and Pharmacology : RTP|November 12, 2009
Enhancing the utility of alanine aminotransferase as a reference standard biomarker for drug-induced liver injuryJosef S Ozer, Raj Chetty, Gerry Kenna, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Toxicologic Pathology|June 8, 2012
Differential effect of troglitazone on the human bile acid transporters, MRP2 and BSEP, in the PXB hepatic chimeric mouseJohn R Foster, Matt Jacobsen, Gerry Kenna, et al.
Archives of Toxicology|May 10, 2012
Systems biology tools for toxicologySuzanne Geenen, Peter Neal Taylor, Jacky L Snoep, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 11, 2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modificationDaniel J Warner, Hongming Chen, Louis-David Cantin, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 2, 2012
Characterization of THLE-cytochrome P450 (P450) cell lines: gene expression background and relationship to P450-enzyme activityYalda Soltanpour, Constanze Hilgendorf, Marie M Ahlström, et al.
Integrative Biology : Quantitative Biosciences From Nano to Macro|May 2, 2013
Multiscale modelling approach combining a kinetic model of glutathione metabolism with PBPK models of paracetamol and the potential glutathione-depletion biomarkers ophthalmic acid and 5-oxoproline in humans and ratsSuzanne Geenen, James W T Yates, J Gerry Kenna, et al.
Regulatory Toxicology and Pharmacology : RTP|February 26, 2022
Use of in vitro metabolism and biokinetics assays to refine predicted in vivo and in vitro internal exposure to the cosmetic ingredient, phenoxyethanol, for use in risk assessmentNicola J Hewitt, John Troutman, Julia Przibilla, et al.
Toxicology Research|August 10, 2018
Improved hepatic physiology in hepatic cytochrome P450 reductase null (HRN™) mice dosed orally with fenclozic acidJames A Akingbasote, Alison J Foster, Huw B Jones, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 15, 2011
HPLC-MS/MS methods for the quantitative analysis of 5-oxoproline (pyroglutamate) in rat plasma and hepatic cell line culture mediumSuzanne Geenen, Cristina Guallar-Hoyas, Filippos Michopoulos, et al.
Chemical Research in Toxicology|December 14, 2012
Bioactivation of the cannabinoid receptor antagonist rimonabant to a cytotoxic iminium ion metaboliteAlison J Foster, Lucy H Prime, Frida Gustafsson, et al.
Regulatory Toxicology and Pharmacology : RTP|November 12, 2009
Enhancing the utility of alanine aminotransferase as a reference standard biomarker for drug-induced liver injuryJosef S Ozer, Raj Chetty, Gerry Kenna, et al.
Pageof 5